跳到主要内容
Learn Motion
探索课程产品能力价格

下载 Learn Motion

用手机扫描二维码,下载 App。

App Store

扫码从 App Store 下载 Learn Motion打开商店页面

Google Play

扫码从 Google Play 下载 Learn Motion打开商店页面
登录
Learn Motion

How AI Designs a Drug Molecule from Scratch

1Why Designing a Drug Molecule Is Hard2Turning Molecules into Something a Machine Can Read3How Generative Models Propose New Molecules4Scoring and Filtering the Candidates5Testing, Learning, and Improving the Design
Why Designing a Drug Molecule Is Hard

What a Drug Molecule Actually Does

1 / 3
Start with the protein on the left. It is the target — a folded chain whose shape creates a pocket. The small molecule on the right is the drug candidate. Watch it settle into that pocket: it is not welded in place, it is held by many weak contacts, so the fit has to be close in both shape and surface chemistry. Once seated, it occupies the site the protein would normally use, and that is what changes the protein's behaviour. Notice how specific this is — a different pocket on a different protein would reject the same molecule.
0:00 / 0:00

Most small-molecule drugs work by binding to a protein. The protein — called the target — is a large folded chain of amino acids with one or more pockets on its surface where small molecules can sit. The drug is a small organic molecule, typically under about 500 daltons, small enough to be absorbed and to reach the protein inside the body.

Binding means the drug settles into a pocket and stays there long enough to matter. It is held by weak, reversible interactions — hydrogen bonds, hydrophobic contact, electrostatic attraction — not by a permanent chemical bond. Because the interactions are weak, the fit has to be good: the drug's shape and the chemical character of its surface must complement the pocket, the way a key matches a lock. A molecule that is the right size but the wrong shape simply does not stay.

Once bound, the drug changes what the protein does. If the target is an enzyme that produces a disease-driving signal, an occupying molecule can block the site where the real substrate would bind, slowing that production. If the target is a receptor, the drug may switch it off or dampen its response. The disease effect follows from that change in protein behaviour, not from the drug acting on the disease directly.

This is why the search is so specific. The requirement is not "a molecule that is active" but "a molecule that fits this particular pocket well enough to alter this particular protein, and does not fit the thousands of other pockets in the body well enough to cause trouble."

1 / 3下一页

Learn Motion

生成课程,认真学会。

运营方:Wuhan Daoyin Technology Co., Ltd.

联系我们: [email protected]
隐私政策用户服务协议

© 2026 Learn Motion